Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy

Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy

Hyperammonemia is a well-known adverse effect of valproate that can progress to a potentially fatal condition known as valproate-induced hyperammonemic encephalopathy (VHE). VHE is more common when valproate is used in combination therapy with other antiepileptic medications. A growing number of cas...

Full description

Bibliographic Details
Main Authors: Kyle Wesselman, PharmD candidate, MA, BS, Vincent Cavaliere, PharmD, MM, BCPP, Rakesh Goyal, MD, Eric Anderson, MD, MBA, FAPA
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2024-02-01
Series:Mental Health Clinician
Subjects:
valproate
encephalopathy
vhe
risperidone
paliperidone palmitate
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.028

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.028

Similar Items